■	DNAVEC is a company with unique technologies through which genes (genetic information), the key to drug generation from now on, are effectively transferred into cells. We intend to make it a platform technology which will play a role in various bio-business dmains.
■	Our company is a genuine “national project-originated venture” based on the outcome of a national project, our antecedent company DNAVEC Research Inc. During its 9 year project, DNAVEC Research Inc. has spread its research activities with unique originality and seniority, and succeeded in the development of innovative vectors that are necessary in the commercialization of gene therapy and use for various bio-business fields. These vectors of Japan-originating technology that have high efficiency and safety have gained many international patents , and have received high evaluations by domesitic and international academic societies and business people as well. Our company is advancing into many-sided cooperative researches and developments with a lot of research organizations and pharmaceutical companies, backed up by such high international evaluation, in order to accomplish the application of its technologies in gene therapy and various other bio-business domains,
■	Our company considers its ultimate mission to be offering a solution to “Unmet Medical Needs,” by making the most of our original vector technologies. Hereafter, we will generate epoch-making medicines as gene therapy drugs and gene vaccines etc, focusing on disorders of the circulation system, respiratory system, nervous system, cancer, infectious diseases (AIDS, SARS etc). Moreover, we will advance the continuous development of high performance vector technology and nurture our technologies into fruitful platform technologies that will bring forth various bio-products.
■	Our greatest delight is to be helpful to patients fighting intractable diseases and to their supporters through giving our full play to our well experienced research staff, abundant research resources and strong network of collaborative researches with domestic and overseas organizations etc, and to basically dedicate our lives to the success of bio-business with frontline technology.